P454 Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease

Authors :: Stéphane Paul
Lieven Pouillon
Camille Zallot
L Peyrin-Biroulet
M. De Carvalho Bittencourt
Anthony Lopez
Xavier Roblin
N Williet
Stéphane Nancey
W. Yacoub
T. Di-Bernado
Source :: Journal of Crohn's and Colitis. 12:S334-S334
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: Crohn's disease
medicine.medical_specialty
business.industry
Gastroenterology
Mucous membrane
General Medicine
medicine.disease
Inflammatory bowel disease
Ulcerative colitis
Vedolizumab
Anti-Tumor Necrosis Factor Therapy
medicine.anatomical_structure
Internal medicine
Mucosal healing
medicine
Trough Concentration
business
medicine.drug

Full Text Access

Tools